Medios AG (FRA:ILM1)

Market Cap	365.24M
Revenue (ttm)	2.01B
Net Income (ttm)	22.03M
Shares Out	n/a
EPS (ttm)	0.87
PE Ratio	16.58
Forward PE	11.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	404
Open	14.34
Previous Close	14.32
Day's Range	14.34 - 14.34
52-Week Range	10.32 - 15.68
Beta	n/a
RSI	56.86
Earnings Date	Nov 11, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2016
• Employees: 952
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ILM1

Financial Performance

In 2024, Medios AG's revenue was 1.88 billion, an increase of 5.51% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.